Natural Capsules Ltd. (NATCAPSUQ) Share Price Rises 10.71% Today

Natural Capsules Ltd. Share Price rises 10.71% to Rs 158.1, with a market cap of Rs 148.67 Cr.

Natural Capsules Ltd. Share Price has experienced a significant rise today, climbing 10.71% to reach Rs 158.1. This increase marks a notable gain from its previous close of Rs 142.8. With a market capitalisation of Rs 148.67 crore, Natural Capsules Ltd. has captured investor attention in the micro-cap category. The stock opened at Rs 148.75 and reached a high of Rs 158.1, reflecting strong upward momentum. The Pharmaceuticals & Drugs industry, where Natural Capsules Ltd. operates, has seen varied performance, making today's price action particularly noteworthy.

The price rise of Natural Capsules Ltd. The micro-cap category, which includes companies with smaller market capitalisations, often sees significant price movements, and Natural Capsules Ltd.'s rise today is a prime example. This event has positioned the company among the top gainers, drawing interest from investors and analysts alike. As we delve deeper into the price action, technical indicators, and fundamental analysis, we aim to provide a comprehensive view of what this means for stakeholders.

Natural Capsules Ltd. (NATCAPSUQ) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 158.1
Previous Close	Rs 142.8
Today's Change	+Rs 15.3 (+10.71%)
Day Open	Rs 148.75
Day High	Rs 158.1
Day Low	Rs 148.3
Current Volume (BSE)	8,993
BSE Traded Volume	8,993
NSE Traded Volume	43,703
Combined NSE + BSE Volume	52,696
Turnover	Rs 0.14 crore
Market Capitalisation	Rs 148.67 crore
Market Cap Category	Micro Cap

Natural Capsules Ltd. (NATCAPSUQ) traded at Rs 158.1. versus the previous close of Rs 142.8, a rise of 10.71%. The stock opened at Rs 148.75, reached Rs 158.1, touched Rs 148.3. Reported volume was 8,993.

Natural Capsules Ltd. (NATCAPSUQ) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 148.67 crore
P/E Ratio	-6.67x
P/B Ratio	0.67x
ROE	19.18%
ROCE	20.75%
EPS	Rs -23.69
Dividend Yield	0%

Natural Capsules Ltd. was valued at a P/E ratio of -6.67x, a P/B ratio of 0.67x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 19.18% and ROCE of 20.75%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs -23.69, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

The company's return on equity (ROE) is 19.18%, and return on capital employed (ROCE) is 20.75%, both of which are above the industry averages of 9.89% and 12.62%, respectively. These figures indicate efficient use of capital and strong profitability relative to peers. However, the negative earnings per share (EPS) of -23.69 reflects challenges in generating positive earnings. The absence of a dividend yield further underscores the company's focus on reinvestment over shareholder payouts.

Overall, Natural Capsules Ltd.'s fundamentals present a mixed picture. While the company demonstrates strong capital efficiency, its negative earnings and low valuation multiples highlight areas for improvement. As we move to ownership analysis, understanding the shareholding pattern will provide further insights into investor sentiment and potential influences on the stock's performance.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	-6.67x
Benchmark Median P/E	24.3x
Benchmark Average P/E	79.96x
Benchmark P/E Range	3.44x to 3,417.8x
Company P/B Ratio	0.67x
Benchmark Median P/B	1.82x
Company ROE	19.18%
Benchmark Median ROE	9.89%
Company ROCE	20.75%
Benchmark Median ROCE	12.62%
Company Market Capitalisation	Rs 148.67 crore
Benchmark Median Market Cap	Rs 141.79 crore

Natural Capsules Ltd. (NATCAPSUQ) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Natural Capsules Ltd. (NATCAPSUQ) has a P/E ratio of -6.67x, which is below the benchmark median of 24.3x, a difference of -127.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Natural Capsules Ltd. (NATCAPSUQ) has a ROE of 19.18%, which is above the benchmark median of 9.89%, a difference of +93.93%. Natural Capsules Ltd. (NATCAPSUQ) has a ROCE of 20.75%, which is above the benchmark median of 12.62%, a difference of +64.42%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Natural Capsules Ltd. operates within the Pharmaceuticals & Drugs industry, a segment of the broader Healthcare sector. The industry comprises 140 companies, with Natural Capsules Ltd.'s P/E ratio of -6.67 standing out against the industry median of 24.3. This negative P/E suggests challenges in profitability, yet the company's P/B ratio of 0.67 is below the industry median of 1.82, indicating potential undervaluation.

The company's ROE of 19.18% and ROCE of 20.75% are both above the industry medians of 9.89% and 12.62%, respectively, showcasing strong operational efficiency. The market capitalisation of Rs 148.67 crore is below the industry median of Rs 141.79 crore, reflecting its position as a smaller player within the sector. The industry itself is diverse, with companies like Dishman Carbogen Amcis Ltd. and Hikal Ltd. representing larger market caps and varied financial metrics.

Overall, Natural Capsules Ltd.'s position within the Pharmaceuticals & Drugs industry is characterized by strong capital efficiency but challenges in profitability. As we explore peer comparisons, these insights will be further contextualized against specific competitors.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,931.84	30.09	0.44	-2.89	-0.26
Hikal Ltd.	HIKAL	2,731.11	0	2.28	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,683.28	39.84	8.11	28.21	26.35
Panacea Biotec Ltd.	PANACEABIO	2,580.49	0	3.09	0	5.36
Beta Drugs Ltd.	BETA	2,474.26	59.65	7.97	18.65	22.17

Natural Capsules Ltd. (NATCAPSUQ) has a P/E ratio of -6.67x compared with the displayed peer median of 30.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.18% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 20.75% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Natural Capsules Ltd. (NATCAPSUQ) has a market capitalisation of Rs 148.67 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

In comparing Natural Capsules Ltd. with its peers, several key differences emerge. Dishman Carbogen Amcis Ltd., with a market cap of Rs 2,931.84 crore, has a P/E of 30.09 and a P/B of 0.44, indicating a more established market presence. Hikal Ltd., with a market cap of Rs 2,731.11 crore, does not have a P/E ratio available but shows a P/B of 2.28, reflecting a higher valuation relative to book value.

Kwality Pharmaceuticals Ltd., with a market cap of Rs 2,683.28 crore, has a P/E of 39.84 and a P/B of 8.11, indicating a premium valuation. In contrast, Natural Capsules Ltd.'s negative P/E and lower P/B suggest potential undervaluation but also highlight profitability challenges. The company's ROE and ROCE are competitive, aligning closely with peers like Beta Drugs Ltd., which has an ROE of 18.65% and ROCE of 22.17%.

Overall, Natural Capsules Ltd. stands out for its capital efficiency, though its valuation metrics indicate areas for improvement. As we consider why investors are watching this stock, these peer comparisons provide valuable context.

Why Investors Are Watching Natural Capsules Ltd.

Natural Capsules Ltd. has captured investor attention due to its significant price rise today, coupled with its strong capital efficiency metrics. The company's position within the Pharmaceuticals & Drugs industry, along with its valuation metrics, offers a compelling case for further analysis.

• Price Action: Share price rose 10.71% to Rs 158.1.
• Technical Position: RSI at 42.67 indicates neutral momentum.
• Fundamental Context: Strong ROE and ROCE despite negative EPS.
• Sector Positioning: Operates within a competitive industry with varied performance.

Investors should monitor Natural Capsules Ltd.'s future earnings performance and industry developments. The company's ability to improve profitability and leverage its capital efficiency will be key factors in its ongoing market performance.

About Natural Capsules Ltd.

Natural Capsules Ltd. is a player in the Pharmaceuticals & Drugs industry, part of the broader Healthcare sector. The company is involved in the manufacturing and marketing of pharmaceutical products, focusing on delivering quality healthcare solutions. With a market capitalisation of Rs 148.67 crore, it operates as a micro-cap entity within a competitive landscape.

The company's business model revolves around producing a range of pharmaceutical products, catering to both domestic and international markets. Despite challenges in profitability, as reflected in its negative EPS, Natural Capsules Ltd. continues to focus on operational efficiency and capital management. Its strong ROE and ROCE metrics highlight its ability to generate returns on invested capital, positioning it as a company with potential for growth and improvement.

Track Natural Capsules Ltd. Share Price on Univest

Use Natural Capsules Ltd. (NATCAPSUQ) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors and analysts can track Natural Capsules Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share price movements, technical indicators, fundamental ratios, and shareholding patterns. Users can also explore 52-week levels and gain market insights to make informed decisions. Stay updated with the latest developments and track Natural Capsules Ltd.'s performance on Univest.

Frequently Asked Questions

What is the current share price of Natural Capsules Ltd.?

Ans. The current share price of Natural Capsules Ltd. is Rs 158.1, reflecting a 10.71% increase from the previous close of Rs 142.8. The stock moved 10.71% during the session. The intraday range extended from Rs 148.3 to Rs 158.1.

Why did Natural Capsules Ltd. Share Price rise today?

Ans. Natural Capsules Ltd. Share Price rose 10.71% today, surpassing the micro-cap category threshold, driven by increased trading volume and market interest. The stock moved 10.71% during the session. The intraday range extended from Rs 148.3 to Rs 158.1.

What is the market capitalisation of Natural Capsules Ltd.?

Ans. The market capitalisation of Natural Capsules Ltd. is Rs 148.67 crore, categorizing it as a micro-cap company within the Pharmaceuticals & Drugs industry. The company operates in the Healthcare sector.

How does Natural Capsules Ltd.'s P/E ratio compare to the industry?

Ans. Natural Capsules Ltd. has a negative P/E ratio of -6.67, contrasting with the industry median P/E of 24.3, indicating profitability challenges. The company trades at a P/E ratio of -6.67x.

What is the ROE of Natural Capsules Ltd.?

Ans. The return on equity (ROE) for Natural Capsules Ltd. is 19.18%, exceeding the industry median of 9.89%, showcasing strong capital efficiency. ROE stands at 19.18%. ROCE stands at 20.75%. The relevant peer median ROE is 9.89%.

How does Natural Capsules Ltd.'s P/B ratio compare to peers?

Ans. Natural Capsules Ltd.'s P/B ratio is 0.67, below the industry median of 1.82, suggesting potential undervaluation relative to book value. The company trades at a P/E ratio of -6.67x. Its P/B ratio is 0.67x.

Which sector does Natural Capsules Ltd. belong to?

Ans. Natural Capsules Ltd. operates within the Healthcare sector, specifically in the Pharmaceuticals & Drugs industry, focusing on pharmaceutical product manufacturing. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.